SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-200029
Filing Date
2022-07-22
Accepted
2022-07-22 16:06:36
Documents
6
Effectiveness Date
2022-07-22

Document Format Files

Seq Description Document Type Size
1 S-8 d385102ds8.htm S-8 41251
2 EX-4.3 d385102dex43.htm EX-4.3 119181
3 EX-5.1 d385102dex51.htm EX-5.1 9427
4 EX-23.1 d385102dex231.htm EX-23.1 2213
5 EX-FILING FEES d385102dexfilingfees.htm EX-FILING FEES 13955
6 GRAPHIC g385102g0721032534708.jpg GRAPHIC 2091
  Complete submission text file 0001193125-22-200029.txt   190119
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-266288 | Film No.: 221100038
SIC: 2836 Biological Products, (No Diagnostic Substances)